Our comparative study of SOX2 negative and positive tumors did not show significant correlations between the SOX2 expression status and other tumor parameters such as grading, breast cancer subtype, hormone receptor or HER2 expression, or presence of lymphangiosis. This evidence concerns the gene ERBB2 and neoplasm.